Brain Device Articles & Analysis
14 news found
This extra fluid puts pressure on the brain and can cause brain damage. Hydrocephalus is characterized by head enlargement in infants. Treatment is often a tube (shunt) inserted surgically into a ventricle of the brain to drain excess fluid, but over time the device can often become dislodged or clogged which then requires more ...
” Relivion is a non-invasive brain neuromodulation device that is placed around the head and delivers stimulation to the occipital and trigeminal nerves. This creates a cumulative effect by releasing neurotransmitters in the brainstem and modulating brain networks associated with control of pain and mood. The device is ...
“Our research is exciting because while other devices require surgery that involves opening the skull, this brain-computer interface device is much less invasive. ...
” Synchron has developed an endovascular brain computer interface that is designed to access every corner of the brain using its natural highways, the blood vessels. ...
NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for “adjunctive use for reducing the frequency of seizures in individuals 18 years of age or older diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary generalization, that are ...
First Quarter and Recent Business Updates Submitted clearance request to FDA for less than 30-day use of NeuroOne's Evo® sEEG Electrode, which has already been 510(k) cleared for temporary (less than 24 hours) use Exhibited our Evo cortical electrode product family at the American Epilepsy Society Meeting in Zimmer Biomet's booth Presented poster with the following title at American ...
Now, the Montreal-based company that Petrecca helped found is poised to solve the problem of residual brain cancer. Reveal Surgical is taking aim at glioblastomas, the most common and fatal type of malignant brain tumour. ...
Synchron, a venture-backed brain data transfer company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for its flagship product, the Stentrode™ motor neuroprosthesis. ...
People recovering from a stroke will soon have access to a device that can help restore a disabled hand. The Food And Drug Administration has authorized a device called IpsiHand from the uninjured side of a patient's brain to help rewire circuits controlling the hand, wrist and arm. ...
FDA Breakthrough Device Designation Neurolutions, Inc., a medical device company developing and commercializing a first-of-its-kind device leveraging brain-computer interface (BCI) technology for upper extremity chronic stroke rehabilitation, announced today that the U.S. ...
Neurolief Ltd., a neurotechnology innovator, today announces that it has entered into an exclusive agreement with Sawai Pharmaceutical Co., Ltd. for the development and marketing of Relivion®, a non-invasive digital medical device for migraine and depression, in Japan. Relivion® is a non-invasive brain neuromodulation* device that is ...
Accessing an FDA compliant EEG device that performs at an uncompromising standard, allows for increased throughput and provides a user experience that rivals the latest technology assets, was very attractive to us. ...
The panel will be focused on next generation strategies for bypassing the blood brain barrier, including devices, carrier and nanovesicle technologies. ...
NDI Medical, LLC, a venture and commercialization firm that funds and develops innovative neurodevice technologies, has launched its next portfolio company, Deep Brain Innovations, LLC (DBI). DBI will commercialize its groundbreaking technology that is designed to optimize deep brain stimulation (DBS) therapy for patients with Parkinson’s disease. ...